Emmessar Biotech & Nutrition reports standalone net profit of Rs 0.52 crore in the March 2021 quarter

Image
Capital Market
Last Updated : May 21 2021 | 5:50 PM IST

Sales rise 425.58% to Rs 4.52 crore

Net profit of Emmessar Biotech & Nutrition reported to Rs 0.52 crore in the quarter ended March 2021 as against net loss of Rs 0.06 crore during the previous quarter ended March 2020. Sales rose 425.58% to Rs 4.52 crore in the quarter ended March 2021 as against Rs 0.86 crore during the previous quarter ended March 2020.

For the full year,net profit rose 93.33% to Rs 1.45 crore in the year ended March 2021 as against Rs 0.75 crore during the previous year ended March 2020. Sales rose 105.59% to Rs 6.99 crore in the year ended March 2021 as against Rs 3.40 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales4.520.86 426 6.993.40 106 OPM %21.68-20.93 -12.16-12.35 - PBDT1.340.19 605 2.321.05 121 PBT1.330.18 639 2.260.99 128 NP0.52-0.06 LP 1.450.75 93

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 21 2021 | 5:35 PM IST

Next Story